JP2022136242A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022136242A5 JP2022136242A5 JP2022119816A JP2022119816A JP2022136242A5 JP 2022136242 A5 JP2022136242 A5 JP 2022136242A5 JP 2022119816 A JP2022119816 A JP 2022119816A JP 2022119816 A JP2022119816 A JP 2022119816A JP 2022136242 A5 JP2022136242 A5 JP 2022136242A5
- Authority
- JP
- Japan
- Prior art keywords
- epinastine
- ophthalmic preparation
- acid
- preparation according
- ophthalmic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WHWZLSFABNNENI-UHFFFAOYSA-N epinastine Chemical compound C1C2=CC=CC=C2C2CN=C(N)N2C2=CC=CC=C21 WHWZLSFABNNENI-UHFFFAOYSA-N 0.000 claims 5
- 229960003449 epinastine Drugs 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 claims 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 238000009472 formulation Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 208000026935 allergic disease Diseases 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- 229960000583 acetic acid Drugs 0.000 claims 1
- 208000002205 allergic conjunctivitis Diseases 0.000 claims 1
- 229960002684 aminocaproic acid Drugs 0.000 claims 1
- 208000024998 atopic conjunctivitis Diseases 0.000 claims 1
- 229960004106 citric acid Drugs 0.000 claims 1
- 229960001484 edetic acid Drugs 0.000 claims 1
- 229960002548 epinastine hydrochloride Drugs 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 229960002989 glutamic acid Drugs 0.000 claims 1
- 150000004677 hydrates Chemical class 0.000 claims 1
- 230000005012 migration Effects 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022119816A JP7628098B2 (ja) | 2020-10-08 | 2022-07-27 | エピナスチン又はその塩を含有する花粉破裂抑制剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020170719A JP7114668B2 (ja) | 2020-10-08 | 2020-10-08 | エピナスチン又はその塩を含有する花粉破裂抑制剤 |
| JP2022119816A JP7628098B2 (ja) | 2020-10-08 | 2022-07-27 | エピナスチン又はその塩を含有する花粉破裂抑制剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020170719A Division JP7114668B2 (ja) | 2020-10-08 | 2020-10-08 | エピナスチン又はその塩を含有する花粉破裂抑制剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022136242A JP2022136242A (ja) | 2022-09-15 |
| JP2022136242A5 true JP2022136242A5 (enrdf_load_stackoverflow) | 2023-10-17 |
| JP7628098B2 JP7628098B2 (ja) | 2025-02-07 |
Family
ID=81210896
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020170719A Active JP7114668B2 (ja) | 2020-10-08 | 2020-10-08 | エピナスチン又はその塩を含有する花粉破裂抑制剤 |
| JP2022119816A Active JP7628098B2 (ja) | 2020-10-08 | 2022-07-27 | エピナスチン又はその塩を含有する花粉破裂抑制剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020170719A Active JP7114668B2 (ja) | 2020-10-08 | 2020-10-08 | エピナスチン又はその塩を含有する花粉破裂抑制剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (2) | JP7114668B2 (enrdf_load_stackoverflow) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102327887B1 (ko) * | 2019-04-10 | 2021-11-17 | 호원대학교산학협력단 | 김 생산 공정의 온도 및 습도를 조절하여 김을 생산하는 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19954516A1 (de) * | 1999-11-12 | 2001-05-17 | Boehringer Ingelheim Int | Epinastin-haltige Lösungen |
| JP2003026565A (ja) * | 2001-07-10 | 2003-01-29 | Senju Pharmaceut Co Ltd | ケトチフェン含有結膜移行性促進水性点眼剤 |
| JP2005263743A (ja) | 2004-03-19 | 2005-09-29 | Rohto Pharmaceut Co Ltd | ロイコトリエン産生抑制作用を有する医薬組成物 |
| EP1901724A1 (en) * | 2005-07-08 | 2008-03-26 | Senju Pharmaceutical Co., Ltd. | Percutaneously absorptive ophthalmic preparation comprising epinastine |
| JP4881268B2 (ja) | 2006-09-25 | 2012-02-22 | あすか製薬株式会社 | 苦味が抑制された経口製剤 |
| US20080194544A1 (en) * | 2007-02-08 | 2008-08-14 | Ramesh Krishnamoorthy | Aqueous formulations of epinastine for treating allergic rhinitis |
| CN103222955A (zh) * | 2013-05-22 | 2013-07-31 | 北京科源创欣科技有限公司 | 含依匹斯汀或其盐酸盐的稳定的溶液剂 |
| JP6918564B2 (ja) | 2017-05-01 | 2021-08-11 | 参天製薬株式会社 | 水性医薬組成物 |
| WO2019176947A1 (ja) | 2018-03-13 | 2019-09-19 | 参天製薬株式会社 | 花粉破裂抑制用組成物 |
| JP7355539B2 (ja) | 2018-07-20 | 2023-10-03 | ロート製薬株式会社 | 眼科組成物 |
| JP2019108320A (ja) | 2018-10-31 | 2019-07-04 | 参天製薬株式会社 | ソフトコンタクトレンズの変質を抑制する眼科用組成物 |
| JP7599838B2 (ja) | 2019-04-10 | 2024-12-16 | 参天製薬株式会社 | エピナスチン又はその塩を含有する水性医薬組成物 |
-
2020
- 2020-10-08 JP JP2020170719A patent/JP7114668B2/ja active Active
-
2022
- 2022-07-27 JP JP2022119816A patent/JP7628098B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115645535B (zh) | 小鼠近视诱导模型及用于近视预防/抑制的内质网应激抑制剂 | |
| CN105307498B (zh) | 用于治疗眼病的组合物、制剂和方法 | |
| US20200338094A1 (en) | Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions | |
| KR101953736B1 (ko) | 제브라피시 모델을 사용한 약물 스크리닝 방법 및 이 방법으로 스크린된 화합물 | |
| JP7248836B2 (ja) | ヘテロシクリデンアセトアミド誘導体含有医薬 | |
| CN110461862A (zh) | 用于治疗由衰老细胞介导的病症和用于治疗癌症的基于肽的蛋白酶体抑制剂 | |
| JP2022136242A5 (enrdf_load_stackoverflow) | ||
| ES3002189T3 (en) | Para-hydroquinone derivatives as vegf, tnf and/or il inhibitors for the treatment of neuroinflammatory diseases | |
| AU2014254621A1 (en) | Orally administrable pharmaceutical composition for prevention or treatment of dry eye syndrome, comprising rebamipide or prodrug thereof | |
| RU2207852C2 (ru) | Средства для предотвращения или лечения болезней, связанных с чрезмерной пролиферацией эпителиальных пигментных клеток сетчатки | |
| CN105705484B (zh) | 作为甲酰肽受体调节剂的苯基氨基甲酸酯衍生物 | |
| CN105142670A (zh) | 用于治疗眼部炎性疾病的滴眼剂组合物及其制备方法 | |
| AU2022297106A1 (en) | Fluorescent probes | |
| JP2016056207A (ja) | プロスタグランジンアゴニストのプロドラッグの安定した水性組成物およびその使用方法 | |
| CN117942385A (zh) | 一种细胞保护的药物组合物及应用 | |
| US20030041339A1 (en) | Experimental animals for evaluation of therapeutic effects on corneal epithelial damages | |
| JP2018534274A (ja) | 一過性受容体電位カチオンチャネルサブファミリーｍメンバー８（ｔｒｐｍ８）拮抗薬及び使用方法 | |
| WO2007066678A1 (ja) | 角結膜障害治療剤 | |
| JP4778515B2 (ja) | 角膜疾患治療剤 | |
| JP4778262B2 (ja) | 角膜疾患治療剤 | |
| RU2827702C1 (ru) | 2,5- или 2,6-дизамещенные производные гидрохинона, содержащие по крайней мере одну карбокси-, сульфо- или амидогруппу, применяемые в качестве лекарственных средств | |
| Bayoumi et al. | Glaucoma Associated with Non-acquired Systemic Diseases or Syndromes | |
| CN119421881A (zh) | 酯类化合物及其应用 | |
| ES2603641T3 (es) | Tratamiento de la isquemia ocular y cerebral | |
| JP2006104199A (ja) | 角結膜障害治療剤 |